With Tekmira’s alternative-track treatment on hold, Sarepta CEO Chris Garabedian has jumped into the media blitz surrounding the Ebola outbreak in Africa, offering to provide the small stock still on the shelves and order up fresh supplies of the Phase I drug.

…read more

Source: Sarepta leaps into Ebola spotlight with a shelved therapy


0 No comments